,46,47,48 As shown by CyTOF analysis, there was a phenotype change in about half of the tumor cells—characterized by upregulation of both anti-inflammatory (PDL1) and inflammatory (H2Db) surface markers in the group treated with IFNγ (Figure 2A). The gene discussed is CD274; the disease is neoplasm.